These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 1047088

  • 1. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA, Courtney KB.
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [Abstract] [Full Text] [Related]

  • 2. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.
    Miller MH, Wexler MA, Steigbigel NH.
    Antimicrob Agents Chemother; 1978 Sep; 14(3):336-43. PubMed ID: 251069
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    Washburn RG, Durack DT.
    J Infect Dis; 1981 Sep; 144(3):237-43. PubMed ID: 6268715
    [Abstract] [Full Text] [Related]

  • 4. Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.
    Murray HW, Wigley FM, Mann JJ, Arthur RR.
    Arch Intern Med; 1976 Apr; 136(4):480-3. PubMed ID: 1267557
    [Abstract] [Full Text] [Related]

  • 5. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

  • 6. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F, Martín-Luengo F, García A, Valdés M.
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [Abstract] [Full Text] [Related]

  • 7. Penicillinase-resistant penicillin/gentamicin synergism. Effect in patients with Staphylococcus aureus bacteremia.
    Licht JH.
    Arch Intern Med; 1979 Oct; 139(10):1094-8. PubMed ID: 258599
    [Abstract] [Full Text] [Related]

  • 8. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G, Valdés M, Pérez R, Martín-Luengo F, García A, Soria F, Gómez J.
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T, Vicente MV, Rodríguez A.
    J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract] [Full Text] [Related]

  • 10. Tolerant Staphylococcus aureus causing vertebral osteomyelitis.
    Musher DM, Fletcher T.
    Arch Intern Med; 1982 Mar; 142(3):632-4. PubMed ID: 6917742
    [Abstract] [Full Text] [Related]

  • 11. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J, Carrizosa J, Kaye D, Kobasa WD.
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [Abstract] [Full Text] [Related]

  • 12. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM, Keeley JM.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [Abstract] [Full Text] [Related]

  • 13. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
    Watanakunakorn C.
    Scand J Infect Dis Suppl; 1983 Dec; 41():151-7. PubMed ID: 6589752
    [Abstract] [Full Text] [Related]

  • 14. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F, Martín Luengo F, Valdés M.
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [Abstract] [Full Text] [Related]

  • 15. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.
    Clin Infect Dis; 2009 Mar 15; 48(6):713-21. PubMed ID: 19207079
    [Abstract] [Full Text] [Related]

  • 16. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Jacqueline C, Asseray N, Batard E, Le Mabecque V, Kergueris MF, Dube L, Bugnon D, Potel G, Caillon J.
    Int J Antimicrob Agents; 2004 Oct 15; 24(4):393-6. PubMed ID: 15380267
    [Abstract] [Full Text] [Related]

  • 17. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ.
    J Infect Dis; 1984 Jun 15; 149(6):904-12. PubMed ID: 6736681
    [Abstract] [Full Text] [Related]

  • 18. The role of vancomycin in the treatment paradigm.
    Stevens DL.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [Abstract] [Full Text] [Related]

  • 19. Experimental endocarditis and fosfomycin.
    Rodríguez A, Vicente MV, Olay T.
    Drugs Exp Clin Res; 1985 Jan 01; 11(1):55-62. PubMed ID: 3836112
    [Abstract] [Full Text] [Related]

  • 20. Staphylococcal myositis in a compromised host. Successful treatment with the synergistic combination of nafcillin and gentamicin.
    Jordan GW, Bauer R, Wong GA, Barry AL.
    West J Med; 1976 Feb 01; 124(2):140-3. PubMed ID: 1061438
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.